<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Viridian Metals Inc — News on 6ix</title>
<link>https://6ix.com/company/viridian-metals-inc</link>
<description>Latest news and press releases for Viridian Metals Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 14 May 2026 15:43:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/viridian-metals-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d6bc8abeedb30cb6ffd462.webp</url>
<title>Viridian Metals Inc</title>
<link>https://6ix.com/company/viridian-metals-inc</link>
</image>
<item>
<title>Viridian Metals Announces Flow-Through Private Placement, Warrant Extension and Date of Annual General and Special Meeting</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-metals-announces-flow-through-private-placement-warrant-extension-and-date-of-annual-general-and-special-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-metals-announces-flow-through-private-placement-warrant-extension-and-date-of-annual-general-and-special-meeting</guid>
<pubDate>Thu, 14 May 2026 15:43:00 GMT</pubDate>
<description>OTTAWA, May 14, 2026 (GLOBE NEWSWIRE) -- Viridian Metals Inc. (CSE: VRDN) (“Viridian” or the “Company”) is pleased to announce that it has entered into a binding subscription agreement with Pavilion Flow- Through L.P. (2026) 1 (the “Investor”) in respect of a non-brokered private placement (the “Private Placement”) of flow-through units of the Company (the “Units”) at a price of $0.52 per Unit for aggregate gross proceeds to the Company of $750,000. The subscription price per Unit represents a p</description>
</item>
<item>
<title>Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-announces-pricing-of-upsized-concurrent-public-offerings-of-175percent-convertible-senior-notes-due-2032-and-common-stock-with-aggregate-gross-proceeds-of-dollar3500-million-1</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-announces-pricing-of-upsized-concurrent-public-offerings-of-175percent-convertible-senior-notes-due-2032-and-common-stock-with-aggregate-gross-proceeds-of-dollar3500-million-1</guid>
<pubDate>Thu, 07 May 2026 03:13:00 GMT</pubDate>
<description>Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, devel...</description>
</item>
<item>
<title>Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-announces-proposed-concurrent-public-offerings-of-convertible-senior-notes-due-2032-common-stock-and-series-b-non-voting-convertible-preferred-stock</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-announces-proposed-concurrent-public-offerings-of-convertible-senior-notes-due-2032-common-stock-and-series-b-non-voting-convertible-preferred-stock</guid>
<pubDate>Tue, 05 May 2026 20:05:00 GMT</pubDate>
<description>Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, devel...</description>
</item>
<item>
<title>Viridian Metals Clarifies Disclosure</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-metals-clarifies-disclosure</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-metals-clarifies-disclosure</guid>
<pubDate>Thu, 16 Apr 2026 04:00:00 GMT</pubDate>
<description>OTTAWA, Ontario, April 16, 2026 (GLOBE NEWSWIRE) -- Viridian Metals Inc. (CSE: VRDN) ("Viridian" or the "Company") wishes to clarify the disclosure in its press</description>
</item>
<item>
<title>Viridian Announces Market Services Agreement With Outside The Box Capital</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-announces-market-services-agreement-with-outside-the-box-capital</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-announces-market-services-agreement-with-outside-the-box-capital</guid>
<pubDate>Wed, 15 Apr 2026 22:29:00 GMT</pubDate>
<description>OTTAWA, Ontario, April 15, 2026 (GLOBE NEWSWIRE) -- Viridian Metals Inc. (CSE: VRDN) ("Viridian" or the "Company") is pleased to announce that it has entered into a marketing services agreement (the "Agreement") effective April 15, 2026 with Outside The Box Capital Inc. ("OTB Capital"), an Ontario-incorporated marketing firm focused on retail investor outreach and digital community development. Under the Agreement, OTB Capital will deliver digital marketing and investor awareness services encomp</description>
</item>
<item>
<title>Viridian Metals Secures $225,000 Maximum JEA Funding; Adopts Quarterly Reporting Exemption</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-metals-secures-dollar225000-maximum-jea-funding-adopts-quarterly-reporting-exemption</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-metals-secures-dollar225000-maximum-jea-funding-adopts-quarterly-reporting-exemption</guid>
<pubDate>Wed, 08 Apr 2026 18:00:00 GMT</pubDate>
<description>OTTAWA, April 08, 2026 (GLOBE NEWSWIRE) -- Viridian Metals Inc. (CSE: VRDN) (“Viridian” or the “Company”) reports that it has been awarded $225,000 under the Junior Exploration Assistance (“JEA”) program, representing the maximum funding available through the program for the 2025 cycle. This funding supported the Company’s 2025 field program at its Sedna Project in Labrador. This marks the third consecutive year Viridian has received the maximum JEA award, following funding received for its 2023</description>
</item>
<item>
<title>Chablis Capital Corp. Enters into Definitive Agreement and Exchange Conditional Approval for Qualifying Transaction</title>
<link>https://6ix.com/company/viridian-metals-inc/news/chablis-capital-corp-enters-into-definitive-agreement-and-exchange-conditional-approval-for-qualifying-transaction</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/chablis-capital-corp-enters-into-definitive-agreement-and-exchange-conditional-approval-for-qualifying-transaction</guid>
<pubDate>Wed, 01 Apr 2026 16:15:00 GMT</pubDate>
<description>Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Chablis Capital Corp. (TSXV: CCZ.P) ("Chablis" or the "Company"), a "capital pool company" under the policies of the TSX Venture Exchange (the "Exchange"), is pleased to announce it has entered into a definitive share exchange agreement on March 31, 2026 (the "Share Exchange Agreement") in respect of its previously announced "qualifying transaction" under the policies of the Exchange (the "Qualifying Transaction") to acquire Viridian Metals...</description>
</item>
<item>
<title>Viridian Therapeutics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-inc-shareholders-are-encouraged-to-reach-out-to-johnson-fistel-for-more-information-about-potentially-recovering-their-losses</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-inc-shareholders-are-encouraged-to-reach-out-to-johnson-fistel-for-more-information-about-potentially-recovering-their-losses</guid>
<pubDate>Tue, 31 Mar 2026 15:00:08 GMT</pubDate>
<description>SAN DIEGO, March 31, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential cla...</description>
</item>
<item>
<title>Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL?1 Clinical Trial in Active Thyroid Eye Disease</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-announces-positive-topline-results-from-elegrobart-phase-3-reveal1-clinical-trial-in-active-thyroid-eye-disease-1</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-announces-positive-topline-results-from-elegrobart-phase-3-reveal1-clinical-trial-in-active-thyroid-eye-disease-1</guid>
<pubDate>Mon, 30 Mar 2026 11:01:00 GMT</pubDate>
<description>- REVEAL-1 met the primary endpoint of Q4W proptosis responder rate (PRR) with a highly statistic...</description>
</item>
<item>
<title>Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-highlights-recent-progress-and-reports-fourth-quarter-and-full-year-2025-financial-results-1</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-highlights-recent-progress-and-reports-fourth-quarter-and-full-year-2025-financial-results-1</guid>
<pubDate>Thu, 26 Feb 2026 12:01:00 GMT</pubDate>
<description>- PDUFA target action date of June 30, 2026 for veligrotug for thyroid eye disease (TED); U.S. co...</description>
</item>
<item>
<title>Viridian Confirms Basin-Scale Plumbing Systems and Copper-Bearing Chemical Traps at the Sedna Project</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-confirms-basin-scale-plumbing-systems-and-copper-bearing-chemical-traps-at-the-sedna-project</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-confirms-basin-scale-plumbing-systems-and-copper-bearing-chemical-traps-at-the-sedna-project</guid>
<pubDate>Wed, 18 Feb 2026 13:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Extensive sediment-hosted copper mineralization within the Seal Basin is now demonstrated to be driven by a deeply rooted, crustal-scale plumbing network beneath Viridian Metals Inc’s (CSE: VRDN) (“Viridian” or the “Company”) Sedna Project in Labrador, Canada. By integrating newly acquired magnetotelluric (“MT”) data with detailed surface mapping, Viridian has defined the geological architecture underpinning this district-scale miner</description>
</item>
<item>
<title>Viridian Continues to Define Large-Scale, Near-Surface Mineralization at Kraken</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-continues-to-define-large-scale-near-surface-mineralization-at-kraken</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-continues-to-define-large-scale-near-surface-mineralization-at-kraken</guid>
<pubDate>Thu, 05 Feb 2026 12:30:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Viridian Metals Inc. (CSE: VRDN) (“Viridian” or the “Company”) is pleased to report final assay results from the remaining 17 drill holes completed during its 2025 drilling program at the Kraken Main Zone, located in Labrador, Canada. Final assays reported from the remaining 17 drill holes completed during the 2025 program at the Kraken Main ZoneConsistent, near-surface sulphide mineralization confirmed over an additional 360 metres</description>
</item>
<item>
<title>Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-2</guid>
<pubDate>Thu, 08 Jan 2026 21:01:00 GMT</pubDate>
<description>Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, devel...</description>
</item>
<item>
<title>Viridian Therapeutics Prepares for Transformational 2026</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-prepares-for-transformational-2026</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-prepares-for-transformational-2026</guid>
<pubDate>Tue, 06 Jan 2026 12:01:00 GMT</pubDate>
<description>- Veligrotug BLA accepted for thyroid eye disease (TED) with PDUFA target action date of June 30,...</description>
</item>
<item>
<title>Viridian Therapeutics Announces BLA Acceptance and Priority Review for Veligrotug for the Treatment of Thyroid Eye Disease</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-announces-bla-acceptance-and-priority-review-for-veligrotug-for-the-treatment-of-thyroid-eye-disease</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-announces-bla-acceptance-and-priority-review-for-veligrotug-for-the-treatment-of-thyroid-eye-disease</guid>
<pubDate>Mon, 22 Dec 2025 12:00:00 GMT</pubDate>
<description>- PDUFA target action date of June 30, 2026 - - Priority Review designation is granted to...</description>
</item>
<item>
<title>Viridian Releases Initial 2025 Drill Results Confirming Shallow, Continuous Sulphide Mineralization at Kraken</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-releases-initial-2025-drill-results-confirming-shallow-continuous-sulphide-mineralization-at-kraken</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-releases-initial-2025-drill-results-confirming-shallow-continuous-sulphide-mineralization-at-kraken</guid>
<pubDate>Wed, 10 Dec 2025 13:00:00 GMT</pubDate>
<description>VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Viridian Metals Inc. (CSE: VRDN) (“Viridian”) is pleased to report initial assay results from the first five holes of its 2025 drilling program at the Kraken Main Zone. The results confirm continuous, near-surface sulphide mineralization across 80 metres of strike (Figure 1), with assays from an additional 360 metres of drilled strike still pending. Several holes returned >20-metre mineralized intervals, including local high-grade co</description>
</item>
<item>
<title>Viridian Metals Announces Closing of First Tranche of Financing and Short Form Vertical Amalgamation</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-metals-announces-closing-of-first-tranche-of-financing-and-short-form-vertical-amalgamation</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-metals-announces-closing-of-first-tranche-of-financing-and-short-form-vertical-amalgamation</guid>
<pubDate>Tue, 02 Dec 2025 21:46:00 GMT</pubDate>
<description>Not for distribution to U.S. news wire services or for dissemination in the United States VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Viridian Metals Inc. (CSE: VRDN) (“Viridian” or the “Company”) is pleased to announce that further to its press release dated November 7, 2025 that it has closed a first tranche (the “First Tranche”) of its non-brokered private placement (the "Offering") consisting of the issuance of a combination of: (i) flow-through shares (“Flow-Through Share</description>
</item>
<item>
<title>Viridian Metals Launches Financing to Build on Positive Market Momentum</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-metals-launches-financing-to-build-on-positive-market-momentum</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-metals-launches-financing-to-build-on-positive-market-momentum</guid>
<pubDate>Fri, 07 Nov 2025 13:23:00 GMT</pubDate>
<description>Viridian Metals Inc. (CSE: VRDN) ("Viridian" or the "Company") is pleased to announce a non-brokered private placement (the "Private Placement") consisting of the issuance of a combination of: (i) flow-through shares of the Company at a price of $0.75 per share, and (ii) non-flow-through units of the Company (each, a "Unit") at a price of $0.56 per Unit, for aggregate gross proceeds to the Company of up to $1,500,000.</description>
</item>
<item>
<title>Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-reports-third-quarter-2025-financial-results-and-highlights-recent-progress</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-reports-third-quarter-2025-financial-results-and-highlights-recent-progress</guid>
<pubDate>Wed, 05 Nov 2025 12:01:00 GMT</pubDate>
<description>- Completed a comprehensive set of financing transactions in October 2025, securing access to up ...</description>
</item>
<item>
<title>Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease</title>
<link>https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-announces-successful-october-submission-of-biologics-license-application-bla-to-us-fda-for-veligrotug-in-thyroid-eye-disease</link>
<guid isPermaLink="true">https://6ix.com/company/viridian-metals-inc/news/viridian-therapeutics-announces-successful-october-submission-of-biologics-license-application-bla-to-us-fda-for-veligrotug-in-thyroid-eye-disease</guid>
<pubDate>Mon, 03 Nov 2025 12:01:00 GMT</pubDate>
<description>- BLA for veligrotug successfully submitted to the U.S. Food and Drug Administration (FDA) in lat...</description>
</item>
</channel>
</rss>